Australia's most trusted
source of pharma news
Posted 15 December 2023 AM
The Federal Government is seeking the public's view on life insurance companies using genetic test results in underwriting, after researchers warned at-risk Aussie's are being deterred from undergoing testing - and thus missing out on targeted therapies.
Ethical, Legal and Social Advisor in Public Genomics at Monash University, Jane Tiller, is leading the push to ban life insurance companies from using genetic test results to discriminate between applicants' risk-rated insurance in Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.